ELOVL2-methylation and renal and cardiovascular event in patients with chronic kidney disease.

BACKGROUND Methylation of the Elongation Of Very Long Chain Fatty Acids-Like 2 (ELOVL2) gene promoter may predict premature ageing and cardiovascular risk. METHODS We studied the cross-sectional associations between blood ELOVL2-methylation and cardiovascular risk factors in 350 patients with chronic kidney disease (CKD) stage G2-G4 aged between 22 and 90 years. In a follow-up study for a mean of 3.9 years, we investigated the association between baseline ELOVL2-methylation and renal or cardiovascular events including death. RESULTS ELOVL2-methylation at seven CpG cites increased with age (the correlation coefficients between 0.67 and 0.87, p < 0.001). The ELOVL2-CpGs methylation was lower in patients with CKD stage G2 versus those in stage G3a, G3b and G4, but the differences were explained by age. ELOVL2-CpGs methylation showed no correlations with cardiovascular risk factors after adjusting for age. During the follow-up, 64 patients showed deterioration in renal function or died and 77 showed cardiovascular events or died. The hazard ratio and 95% confidence intervals for renal or cardiovascular events according to baseline ELOVL2-CpGs methylation were not significant after adjustment for covariates. CONCLUSIONS ELOVL2-hypermethylation showed a strong association with age, but was not independently associated with cardiovascular risk factors or with future renal or cardiovascular events in patients with CKD. ELOVL2 gene methylation is not likely to be itself a cause for ageing or illnesses, but it could be rather influenced by other upstream processes that deserve investigation.

[1]  V. Lagani,et al.  An ELOVL2-Based Epigenetic Clock for Forensic Age Prediction: A Systematic Review , 2022, International journal of molecular sciences.

[2]  Y. Li,et al.  Lipid metabolism dysfunction induced by age-dependent DNA methylation accelerates aging , 2022, Signal Transduction and Targeted Therapy.

[3]  E. Colicino,et al.  Integrative analysis of clinical and epigenetic biomarkers of mortality , 2022, medRxiv.

[4]  D. Gianola,et al.  Prediction of biological age and evaluation of genome-wide dynamic methylomic changes throughout human aging , 2021, G3.

[5]  T. García-Gasca,et al.  Influence of Single Nucleotide Polymorphisms of ELOVL on Biomarkers of Metabolic Alterations in the Mexican Population , 2020, Nutrients.

[6]  Daniel L. Chao,et al.  Elovl2 Is Required for Robust Visual Function in Zebrafish , 2020, bioRxiv.

[7]  Daniel L. Chao,et al.  ELOVL2: Not just a biomarker of aging , 2020, Translational medicine of aging.

[8]  M. Poetsch,et al.  Inter-laboratory adaption of age estimation models by DNA methylation analysis—problems and solutions , 2020, International Journal of Legal Medicine.

[9]  Daniel L. Chao,et al.  The lipid elongation enzyme ELOVL2 is a molecular regulator of aging in the retina , 2019, bioRxiv.

[10]  J. Deleuze,et al.  Evaluation of six blood-based age prediction models using DNA methylation analysis by pyrosequencing , 2019, Scientific Reports.

[11]  C. Zoccali,et al.  Validation of echocardiographic criteria for the clinical diagnosis of heart failure in chronic kidney disease , 2018, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[12]  D. Fliser,et al.  Symmetric dimethylarginine (SDMA) outperforms asymmetric dimethylarginine (ADMA) and other methylarginines as predictor of renal and cardiovascular outcome in non-dialysis chronic kidney disease , 2018, Clinical Research in Cardiology.

[13]  G. Castellani,et al.  Systemic Age-Associated DNA Hypermethylation of ELOVL2 Gene: In Vivo and In Vitro Evidences of a Cell Replication Process , 2017, The journals of gerontology. Series A, Biological sciences and medical sciences.

[14]  I. Xenarios,et al.  Molecular phenotyping of multiple mouse strains under metabolic challenge uncovers a role for Elovl2 in glucose-induced insulin secretion , 2017, Molecular metabolism.

[15]  R. Marioni,et al.  The epigenetic clock and telomere length are independently associated with chronological age and mortality , 2016, International journal of epidemiology.

[16]  S. Horvath,et al.  Decreased epigenetic age of PBMCs from Italian semi-supercentenarians and their offspring , 2015, Aging.

[17]  J. Vaupel,et al.  University of Southern Denmark DNA methylation age is associated with mortality in a longitudinal Danish twin study , 2015 .

[18]  R. Decorte,et al.  Improved age determination of blood and teeth samples using a selected set of DNA methylation markers , 2015, Epigenetics.

[19]  F. Milagro,et al.  Differential DNA Methylation in Relation to Age and Health Risks of Obesity , 2015, International journal of molecular sciences.

[20]  T. Hansen,et al.  Impact of age, BMI and HbA1c levels on the genome-wide DNA methylation and mRNA expression patterns in human adipose tissue and identification of epigenetic biomarkers in blood. , 2015, Human molecular genetics.

[21]  S. Horvath,et al.  DNA methylation age of blood predicts all-cause mortality in later life , 2015, Genome Biology.

[22]  Steve Horvath,et al.  The epigenetic clock is correlated with physical and cognitive fitness in the Lothian Birth Cohort 1936 , 2015, International journal of epidemiology.

[23]  A. Go,et al.  Fibroblast growth factor-23 and cardiovascular events in CKD. , 2014, Journal of the American Society of Nephrology : JASN.

[24]  T. Ideker,et al.  Genome-wide methylation profiles reveal quantitative views of human aging rates. , 2013, Molecular cell.

[25]  Martin J. Aryee,et al.  Epigenome-wide association data implicate DNA methylation as an intermediary of genetic risk in Rheumatoid Arthritis , 2013, Nature Biotechnology.

[26]  G. Castellani,et al.  Methylation of ELOVL2 gene as a new epigenetic marker of age , 2012, Aging cell.

[27]  M. Capecchi,et al.  ELOVL2 controls the level of n-6 28:5 and 30:5 fatty acids in testis, a prerequisite for male fertility and sperm maturation in mice , 2011, Journal of Lipid Research.

[28]  R. Westerberg,et al.  Fatty acid elongases in mammals: their regulation and roles in metabolism. , 2006, Progress in lipid research.

[29]  R. Płoski,et al.  Examination of DNA methylation status of the ELOVL2 marker may be useful for human age prediction in forensic science. , 2015, Forensic Science International: Genetics.